This is a Single Center, Open-label Prospective Study to Evaluate the Effect of Xiidra® (Lifitegrast Ophthalmic Solution 5.0%) on Tear Film Biomarkers in Dry Eye

Clinical trial NCT07490535 · NOT_YET_RECRUITING

Trial details

NCT number: NCT07490535
Sponsor: Pittsburgh Research Institute
Status: NOT_YET_RECRUITING
Phase: Phase 4
Study type: INTERVENTIONAL

Ocular Surface Disease Dry Eye Syndrome (DES)

Start date: 2026-03-01
Primary completion: 2026-09-01
Enrollment: 36

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.